Celebrex News and Research

RSS
Celecoxib is a non-steroidal anti-inflammatory drug (NSAID) used in the treatment of osteoarthritis, rheumatoid arthritis, acute pain, painful menstruation and menstrual symptoms, and to reduce numbers of colon and rectum polyps in patients with familial adenomatous polyposis. It is marketed by Pfizer. It has the brand name Celebrex and Celebra (in other countries) for arthritis and Onsenal for polyps. Celecoxib is available by prescription in capsule form.
New discovery could aid in synthesis of radiotracers for use with PET scanning

New discovery could aid in synthesis of radiotracers for use with PET scanning

Arthritis drug increases effectiveness of antidepressants in bipolar patients

Arthritis drug increases effectiveness of antidepressants in bipolar patients

Common pain and anti-inflammation drugs may slow cancer growth

Common pain and anti-inflammation drugs may slow cancer growth

American Pain Society releases new post-surgical pain management guideline

American Pain Society releases new post-surgical pain management guideline

Kitov announces more data from Phase III trial on the favorable blood pressure effects of KIT-302

Kitov announces more data from Phase III trial on the favorable blood pressure effects of KIT-302

Kitov Pharmaceuticals' KIT-302 drug candidate meets primary efficacy endpoint in Phase III clinical trial

Kitov Pharmaceuticals' KIT-302 drug candidate meets primary efficacy endpoint in Phase III clinical trial

Vitamin D3 and metformin show promising results in preventing colorectal cancer

Vitamin D3 and metformin show promising results in preventing colorectal cancer

Viagra can have anti-cancer, anti-Alzheimer's disease effects if used with new drugs

Viagra can have anti-cancer, anti-Alzheimer's disease effects if used with new drugs

New study reveals how COX-2 inhibitors can increase risk of heart attack in arthritis patients

New study reveals how COX-2 inhibitors can increase risk of heart attack in arthritis patients

Mylan announces U.S. launch of Celecoxib Capsules

Mylan announces U.S. launch of Celecoxib Capsules

Taking NSAIDs with other drugs can increase risk of upper GI bleeding, study finds

Taking NSAIDs with other drugs can increase risk of upper GI bleeding, study finds

Researchers create combination drug that controls both tumor growth and metastasis

Researchers create combination drug that controls both tumor growth and metastasis

U.S. Court awards Teva favorable decision for generic Celebrex

U.S. Court awards Teva favorable decision for generic Celebrex

Actavis' subsidiary files lawsuit against FDA over Celebrex decision

Actavis' subsidiary files lawsuit against FDA over Celebrex decision

Mylan challenges FDA's decision regarding generic drug marketing exclusivity on Celecoxib Capsules

Mylan challenges FDA's decision regarding generic drug marketing exclusivity on Celecoxib Capsules

Aspirin can lower colon cancer risk among people with high levels of specific gene

Aspirin can lower colon cancer risk among people with high levels of specific gene

Penn study clarifies action of potential new class of pain relievers that may benefit and not hurt heart

Penn study clarifies action of potential new class of pain relievers that may benefit and not hurt heart

Certain drugs in Obamacare plans carry hefty pricetags

Certain drugs in Obamacare plans carry hefty pricetags

First Edition: March 24, 2013

First Edition: March 24, 2013

People with intermittent explosive disorder elevate levels of markers of systemic inflammation in blood

People with intermittent explosive disorder elevate levels of markers of systemic inflammation in blood